Participated · Series B · Nov 2025

Santa Barbara-based Sovato provides software and connectivity that lets health systems safely scale telesurgery programs by linking expert surgeons to distant robotic surgical systems. The platform is device-agnostic, already integrated with several leading robots, and has proven safety and feasibility in pre-clinical cases conducted hundreds to thousands of miles apart both domestically and internationally. By allowing a hub-and-spoke model in which one surgical team can serve multiple sites, Sovato helps address global surgeon shortages and geographic disparities in care. The company is collaborating with healthcare providers, robotic manufacturers, and standards bodies to establish operational guidelines for remote robotic surgery programs. Market tailwinds are strong, with the global robotic surgery sector projected to grow 12.4% annually through 2030 and more than 246 companies active in the space. Founded by Cynthia Perazzo and surgical robotics pioneer Dr. Yulun Wang, Sovato has raised $41 million to date, including its recent Series B, to accelerate product development and deepen industry partnerships.

Led · Seed · Feb 2022

PharmD Live is a pharmacist-led telehealth provider based in Washington, DC, focused on reducing adverse drug effects. It delivers telehealth services through a nationwide network of clinical pharmacists combined with AI-driven technology that identifies, predicts, and prevents medication risks and gaps in care. The company uses a personalized, proactive care-delivery model intended to improve patient outcomes, drive clinical efficiency, and increase value-based profitability. Led by CEO Cynthia Nwaubani, PharmD Live partners with doctors to support patients with chronic conditions. The company plans to use recent funding to expand its base of operations and scale its support for clinicians.

Participated · Series C · Jun 2019

Vida Health offers a clinically validated virtual cardiometabolic care platform that combines prescriptive and behavioral therapies through an AI-powered personalized mobile app and a national network of providers. Its programs include video sessions, asynchronous messaging, and digital content to prevent and manage diabetes, obesity, hypertension, and related mental health conditions. Vida emphasizes a body-and-mind approach and says it was an early innovator—integrating Cognitive Behavioral Therapy into cardiometabolic care, launching a full Spanish intervention, and combining behavior change with GLP-1 prescribing. Some of America’s largest employers and health plans are customers, and the company markets its model on delivering clinical and financial outcomes for whole populations. Vida frames its mission as increasing access to innovative, lower-cost treatments to improve patient outcomes and address growing unmet needs in cardiometabolic disease, which affects roughly 40% of U.S. adults. The company intends to further scale and pursue growth opportunities in the rapidly expanding GLP-1 market, where demand is projected to reach $100 billion by 2030. Vida Health operates a virtual chronic care platform that combines an AI-powered, personalized app with video sessions, messaging, and a network of licensed clinicians, coaches, dietitians, and diabetes educators. The company focuses on integrated mental and physical care, with heavily used programs for Type 2 diabetes and mental health. Vida has more than tripled its revenue since the beginning of 2020 and expanded its clinician network by over 400%; more than 400,000 people with diabetes currently have access to Vida’s services. The company launched a complete, full-stack Spanish experience and reports a 6000% increase in therapy sessions last year, with multiple JMIR studies showing A1C reductions and improvements in depression/anxiety outcomes. Vida plans to use new funding to grow its clinician and coaching network, deepen machine-learning capabilities, broaden commercial efforts, and scale its nationwide mental health coaching program. Clients include employers such as Boeing, Visa, Cisco, and eBay, and large health plans including Centene, Humana, and Blue Cross Blue Shield plans. Vida Health is a virtual care platform built to treat multiple chronic health conditions simultaneously using machine learning alongside human health coaches and therapists. Launched in 2014 and led by CEO Stephanie Tilenius, the company delivers services via a mobile platform that supports prevention, management and reversal of conditions such as pre‑diabetes, diabetes, hypertension, obesity, depression and anxiety. The platform integrates deep individual expert care with data‑driven technology and remote monitoring. Vida sells its services to employers and health plans to deliver improved health outcomes and cost savings. In January 2020 the company raised $25M in funding led by Ally Bridge Group with participation from returning investors including AME Cloud Ventures, Aspect Ventures, Canvas Ventures, NGP Capital, Webb Investment Network and Workday Ventures. Vida says it will use the funds to expand operations and broaden its business reach. Vida Health is a personalized virtual care platform that combines digital therapeutic programs with health coaching and therapy delivered via mobile and online channels. The platform supports individuals in managing and reversing chronic physical and behavioral health conditions such as pre-diabetes, diabetes, hypertension, obesity, depression and anxiety. The company is led by founder and CEO Stephanie Tilenius and is based in San Francisco. Vida is deployed by Fortune 1000 employers and healthcare organizations, with customers including Avalon Bay, eBay, PayPal, Steelcase, FICO, Cisco, Visa, Veterans Affairs, MD Anderson Cancer Center, Aurora Health Care and Partners Healthcare. In June 2019 the company closed a $30M Series C and said it will use the funds to expand sales and marketing and to grow its national coaching and therapy network. Investors in the round included GuideWell Mutual Holding Corporation, Teladoc Health, Workday Ventures and existing backers Canvas, Aspect Ventures and NGP Capital. Vida Health offers a HIPAA-compliant, subscription-based app that pairs patients with a network of thousands of health coaches, from nutritionists to therapists. Its platform addresses more than 25 chronic conditions and integrates data from users' doctors, insurers, and up to 100 apps and devices (including MyFitnessPal, Garmin, Fitbit, Strava, and Apple Watch). Vida serves both direct-to-consumer users and enterprise customers, with clients that include Stanford, Duke University, MD Anderson Cancer Center, United Healthcare, and eBay. The company says “tens of thousands” of people have received coaching on the platform and that it has collected more than 7 million data points. Vida is paid by both employers and insurance companies, though the CEO declined to specify whether D2C or enterprise revenue is larger. The company aims to use its accumulated data to improve and expand its product effectiveness over time.